Role of the p50 subunit of NF-κB in vitamin E-induced changes in mice treated with the peroxisome proliferator, ciprofibrate

Food and Chemical Toxicology

Volumn 46, Issue 6, 2008, Pages 2062-2073

  Calfee Mason, Karen G ^a   Lee, Eun Y ^b   Spear, Brett T ^a,b   Glauert, Howard P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cell proliferation; Ciprofibrate; NF B; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CIPROFIBRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIET; DNA BINDING; DRUG INHIBITION; FEEDING BEHAVIOR; FEMALE; MOUSE; NONHUMAN; OXIDATIVE STRESS;

ACYL-COA OXIDASE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BODY WEIGHT; CELL NUCLEUS; CLOFIBRIC ACID; CYCLINS; DIET; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GLUTATHIONE; LIVER; MICE; NF-KAPPA B P50 SUBUNIT; NUCLEASE PROTECTION ASSAYS; ORGAN SIZE; PEROXISOME PROLIFERATORS; RNA; TRANSCRIPTION FACTOR RELA; VITAMIN E;

MUS; RODENTIA;

EID: 42749097181     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.01.047     Document Type: Article

References (63)

1. Azzi A., Aratri E., Boscoboinik D., Clement S., Ozer N.K., Ricciarelli R., and Spycher S. Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation. Biofactors 7 (1998) 3-14
2. Azzi A., Boscoboinik D., Marilley D., Ozer N.K., Stauble B., and Tasinato A. Vitamin E: a sensor and an information transducer of the cell oxidation state. Am. J. Clin. Nutr. 62 (1995) 1337S-1346S
3. Baichwal V.R., and Baeuerle P.A. Apoptosis: Activate NF-kappa B or die?. Curr. Biol. 7 (1997) R94-R96
4. Barkett M., and Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6910-6924
5. Barnett K., Fokum F., and Malafa M. Vitamin E succinate inhibits colon cancer liver metastases. J. Surg. Res. 106 (2002) 292-298
6. Bayly A.C., Roberts R.A., and Dive C. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol. 125 (1994) 197-203
7. Boscoboinik D., Szewczyk A., and Azzi A. Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 286 (1991) 264-269
8. Boscoboinik D., Szewczyk A., Hensey C., and Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266 (1991) 6188-6194
9. Bursch W., Lauer B., Timmermann-Trosiener I., Barthel G., Schuppler J., and Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5 (1984) 453-458
10. Buttriss J.L., and Diplock A.T. High-performance liquid chromatography methods for vitamin E in tissues. Methods Enzymol. 105 (1984) 131-138
11. Calfee-Mason K.G., Spear B.T., and Glauert H.P. Vitamin E inhibits hepatic NF-kappa B activation in rats administered the hepatic tumor promoter, phenobarbital. J. Nutr. 132 (2002) 3178-3185
12. Calfee-Mason K.G., Spear B.T., and Glauert H.P. Effects of vitamin E on the NF-kB pathway in rats treated with the peroxisome proliferator, ciprofibrate. Toxicol. Appl. Pharmacol. 199 (2004) 1-9
13. Chen E., and Li C.C. Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase. Biochem. Biophys. Res. Commun. 249 (1998) 728-734
14. Chevalier S., Macdonald N., and Roberts R.A. Induction of DNA replication by peroxisome proliferators is independent of both tumour necrosis factor a priming and EGF-receptor tyrosine kinase activity. J. Cell Sci. 112 (1999) 4785-4791
15. Cimino F., Esposito F., Ammendola R., and Russo T. Gene regulation by reactive oxygen species. Curr. Top. Cell. Regul. 35 (1997) 123-148
16. Corton J.C., Lapinskas P.J., and Gonzalez F.J. Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 448 (2000) 139-151
17. Dalton T.P., Shertzer H.G., and Puga A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 67-101
18. DeAngelis R.A., Kovalovich K., Cressman D.E., and Taub R. Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice. Hepatology 33 (2001) 915-924
19. Deryckere F., and Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16 (1994) 405
20. Desai I.D. Vitamin E analysis methods for animal tissues. Methods Enzymol. 105 (1984) 138-147
21. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
22. Gill J.H., James N.H., Roberts R.A., and Dive C. The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFb1, DNA damage and Fas. Carcinogenesis 19 (1998) 299-304
23. Gius D., Botero A., Shah S., and Curry H.A. Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. Toxicol. Lett. 106 (1999) 93-106
24. Glauert H.P. Modification of the activation of NF-kB by vitamin E. In: Preedy V.R., and Watson R.R. (Eds). The Encyclopedia of Vitamin E (2007), CABI Publishing, Oxfordshire 353-364
25. Glauert H.P., Beaty M.M., Clark T.D., Greenwell W.S., Tatum V., Chen L.C., Borges T., Clark T.L., Srinivasan S.R., and Chow C.K. Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate. J. Cancer Res. Clin. Oncol. 116 (1990) 351-356
26. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19 (1999) 5785-5799
27. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., and Strauss M. NF-kB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-Phase transition. Mol. Cell. Biol. 19 (1999) 2690-2698
28. Johnson D.G., and Walker C.L. Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 295-312
29. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
30. King K.L., and Cidlowski J.A. Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 60 (1998) 601-617
31. Kitamura T., Watanabe S., and Sato N. Liver regeneration, liver cancers and cyclins. J. Gastroenterol. Hepatol. 13 Suppl. (1998) S96-S99
32. Klaunig J.E., Xu Y., Bachowski S., Ketcham C.A., Isenberg J.S., Kolaja K.L., Baker T.K., Walborg Jr. E.F., and Stevenson D.E. Oxidative stress in nongenotoxic carcinogenesis. Toxicol. Lett. (1995) 683-691
33. Kolaja K.L., and Klaunig J.E. Vitamin E modulation of hepatic focal lesion growth in mice. Toxicol. Appl. Pharmacol. 143 (1997) 380-387
34. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 11 (1997) 118-124
35. Lee H.H., Dadgostar H., Cheng Q., Shu J., and Cheng G. NF-kB-mediated up-regulatin of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96 (1999) 9136-9141
36. Li Y., Leung L.K., Glauert H.P., and Spear B.T. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity. Carcinogenesis 17 (1996) 2305-2309
37. Lock E.A., Mitchell A.M., and Elcombe C.R. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 29 (1989) 145-163
38. Lu Z., Lee E.Y., Robertson L.W., Glauert H.P., and Spear B.T. Effect of 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB-153) on hepatocyte proliferation and apoptosis in mice deficient in the p50 subunit of the transcription factor NF-kB. Toxicol. Sci. 81 (2004) 35-42
39. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12 (1993) 2005-2015
40. Min J., Guo J., Zhao F., and Cai D. Effect of different vitamin E homologous analogues on human hepatoma cell HepG2 proliferation in vitro. Wei Sheng Yan Jiu 32 (2003) 40-43
41. Nilakantan V., Spear B.T., and Glauert H.P. Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate. Carcinogenesis 19 (1998) 631-637
42. O'Brien M.L., Spear B.T., and Glauert H.P. Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit. Rev. Toxicol. 35 (2005) 61-88
43. Palmer H.J., and Paulson K.E. Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr. Rev. 55 (1997) 353-361
44. Poosch M.S., and Yamazaki R.K. Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim. Biophys. Acta 884 (1986) 585-593
45. Rahman I., Biswas S.K., Jimenez L.A., Torres M., and Forman H.J. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid Redox Signal 7 (2005) 42-59
46. Rao M.S., and Reddy J.K. An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ. Health Perspect. 93 (1991) 205-209
47. Reddy J.K., Azarnoff D.L., Svoboda D.J., and Prasad J.D. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response. J. Cell Biol. 61 (1974) 344-358
48. Reddy J.K., and Kumar N.S. Stimulation of catalase synthesis and increase of carnitine acetyltransferase activity in the liver of intact female rats fed clofibrate. J. Biochem. (Tokyo) 85 (1979) 847-856
49. Reddy J.K., and Lalwani N.D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12 (1983) 1-58
50. Reeves P.G., Nielsen F.H., and Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A diet. J. Nutr. 123 (1993) 1939-1951
51. Ridnour L.A., Winters R.A., Ercal N., and Spitz D.R. Measurement of glutathione, glutathione disulfide, and other thiols in mammalian cell and tissue homogenates using high-performance liquid chromatography separation of N-(1-pyrenyl)maleimide derivatives. Methods Enzymol. 299 (1999) 258-267
52. Rininger J.A., Goldsworthy T.L., and Babish J.G. Time course comparison of cell-cycle protein expression following partial hepatectomy and WY14,643-induced hepatic cell proliferation in F344 rats. Carcinogenesis 18 (1997) 935-941
53. Rininger J.A., Wheelock G.D., Ma X., and Babish J.G. Discordant expression of the cyclin-dependent kinases and cyclins in rat liver following acute administration of the hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY14,643). Biochem. Pharmacol. 52 (1996) 1749-1755
54. Roberts R.A., James N.H., Hasmall S.C., Holden P.R., Lambe K., Macdonald N., West D., Woodyatt N.J., and Whitcome D. Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha. Toxicol. Lett. (2000) 49-57
55. Roberts R.A., Soames A.R., Gill J.H., James N.H., and Wheeldon E.B. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis 16 (1995) 1693-1698
56. Sakai M., Okabe M., Yamasaki M., Tachibana H., and Yamada K. Induction of apoptosis by tocotrienol in rat hepatoma dRLh-84 cells. Anticancer Res. 24 (2004) 1683-1688
57. Schramm H., Robertson L.W., and Oesch F. Differential regulation of hepatic glutathione transferase and glutathione peroxidase activities in the rat. Biochem. Pharmacol. 34 (1985) 3735-3739
58. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
59. Sohlenius A.K., Andersson K., and DePierre J.W. The effects of perfluoro-octanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice. Biochem. J. 285 (1992) 779-783
60. Sundseth S.S., and Waxman D.J. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J. Biol. Chem. 267 (1992) 3915-3921
61. Tharappel J.C., Cunningham M.L., Spear B.T., and Glauert H.P. Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate. Toxicol. Sci. 62 (2001) 20-27
62. Tharappel J.C., Nalca A., Owens A.B., Ghabrial L., Konz E.C., Glauert H.P., and Spear B.T. Cell proliferation and apoptosis are altered in mice deficient in the NF-kB p50 subunit after treatment with the peroxisome proliferator ciprofibrate. Toxicol. Sci. 75 (2003) 300-308
63. Yeldandi A.V., Rao M.S., and Reddy J.K. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448 (2000) 159-177